BRIEF published on 11/13/2024 at 07:05, 8 days 3 hours ago Interparfums Projects Steady Growth Through 2025 Interparfums 2025 Sales Forecast Solférino Launch Lacoste Performance High-end Fragrance
REGULATED PRESS RELEASE published on 11/13/2024 at 07:00, 8 days 3 hours ago 2025 outlook. Solid growth Interparfums projects solid growth in 2025 with the launch of the Solférino brand and expansion of key fragrances, targeting high-end market. Sales expected to reach €910-930 million Sales Growth Interparfums Fragrances High-End Market Solférino
BRIEF published on 11/07/2024 at 11:08, 13 days 23 hours ago Monthly declaration of voting rights at Inter Parfums Share Capital Voting Rights Euronext Actions INTER PERFUMES
BRIEF published on 10/22/2024 at 07:05, 30 days 3 hours ago Inter Parfums Reports 20% Sales Increase in Q3 2024 Inter Parfums Fragrance Market Q3 2024 Sales Regional Growth Lacoste Launch
REGULATED PRESS RELEASE published on 10/22/2024 at 07:00, 30 days 3 hours ago Q3 2024 sales: €258m (+20%) Interparfums reports Q3 2024 sales of €257.6m (+20%), driven by top brands like Jimmy Choo and Lacoste fragrances. Positive growth seen in various regions Interparfums Growth Fragrances Q3 2024 Sales Perfume Market
BRIEF published on 10/04/2024 at 15:29, 1 month 16 days ago Inter Parfums: Update of voting rights and shares as of September 30, 2024 Share Capital Voting Rights Actions Financial Markets INTER PERFUMES
BRIEF published on 09/10/2024 at 07:05, 2 months 11 days ago Robust Results for INTER PARFUMS in H1 2024 Financial Performance Net Income Operating Margin Inter Parfums H1 2024 Results
REGULATED PRESS RELEASE published on 09/10/2024 at 07:00, 2 months 11 days ago Robust results in H1 2024: Operating margin: 21.9% - Net margin: 16.5% Interparfums reports strong financial performance in H1 2024 with operating margin at 21.9% and net margin at 16.5%. Company anticipates solid second half results and confirms full-year sales target Financial Performance Interparfums Operating Margin H1 2024 Sales Target
BRIEF published on 09/02/2024 at 17:36, 2 months 18 days ago Inter Parfums: Monthly Declaration of Voting Rights and Shares as of August 31, 2024 Share Capital Voting Rights Actions Monthly Statement INTER PERFUMES
BRIEF published on 08/27/2024 at 11:34, 2 months 24 days ago INTER PARFUMS: Monthly declaration of voting rights and shares as of July 31, 2024 Voting Rights Capital Actions July 2024 INTER PERFUMES
Published on 11/21/2024 at 10:03, 55 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 58 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 58 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 23 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 33 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 28 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 53 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 55 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 58 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 58 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 4 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 38 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 13 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 13 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
